CD8A and cancer: Our study revealed that the TME endowed TAMs with high ID1 expression, which interacts with STAT1 to inhibit CCL4 and SerpinB2 transcription, two STAT1 target genes, leading to CD8+ T cell exclusion in tumor sites and cancer stemness traits maintenance (Supplementary Fig. 8).